Skip to main content
SpringerLink
Log in

Endometrial Carcinoma

  • Chapter
Diagnosis of Endometrial Biopsies and Curettings

Endometrial adenocarcinoma is the most common malignant tumor of the female genital tract in the United States. This neoplasm represents a biologically and morphologically diverse group of tumors, with differing pathogenesis. These tumors have two basic clinicopathologic forms, type I and type II. These two forms of endometrial carcinoma display different clinicopathologic, immunohistochemical, and molecular biologic features suggesting two pathways of carcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Smith M, McCartney AJ. Occult, high-risk endometrial cancer. Gynecol Oncol 1985; 22:154–161.

    PubMed  Google Scholar 

  2. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983; 15:10.

    PubMed  CAS  Google Scholar 

  3. Ronnett BM, Zaino RJ, Ellenson LH, Kurman RJ. Endometrial carcinoma. In: Kurman RJ, ed. Blaustein’s pathology of the female genital tract. 5th ed. New York: Springer-Verlag; 2002: 501–559.

    Google Scholar 

  4. Sherman ME. Theories of endometrial carcinogenesis: A multidisciplinary approach. Mod Pathol 2000; 13:295–308.

    PubMed  CAS  Google Scholar 

  5. Longacre TA, Hendrickson MR. Diffusely infiltrative endometrial adenocarcinoma: an adenoma malignum pattern of myoinvasion. Am J Surg Pathol 1999; 23:69–78.

    PubMed  CAS  Google Scholar 

  6. Landry D, Mai KT, Senterman MK, Perkins DG, Yazdi HM, Veinot JP, et al. Endometrioid adenocarcinoma of the uterus with a minimal deviation invasive pattern. Histopathology 2003; 42:77–82.

    PubMed  CAS  Google Scholar 

  7. Alberhasky RC, Connelly PJ, Christopherson WM. Carcinoma of the endometrium. IV. Mixed adenosquamous carcinoma. Am J Clin Pathol 1982; 77:655–664.

    PubMed  CAS  Google Scholar 

  8. Christopherson WM, Alberhasky RC, Connelly PJ. Carcinoma of the endometrium. I. A clinicopathologic study of clear cell carcinoma and secretory carcinoma. Cancer 1982; 49:1511–1523.

    PubMed  CAS  Google Scholar 

  9. Christopherson WM, Connelly PJ, Alberhasky RC. Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and stage I disease. Cancer 1983; 51:1705–1709.

    PubMed  CAS  Google Scholar 

  10. Connelly PJ, Alberhasky RC, Christopherson WM. Carcinoma of the endometrium. III. Analysis of 865 cases of adenocarcinoma and adenoacanthoma. Obstet Gynecol 1982; 59:569–575.

    PubMed  CAS  Google Scholar 

  11. Hendrickson M, Ross J, Eifel PJ, Cox RJ, Martinez A, Kempson R. Adenocarcinoma of the endometrium: An analysis of 256 cases with carcinoma limited to the uterine corpus. I. Pathology review and analysis of prognostic variables. Gynecol Oncol 1982; 13:373–392.

    PubMed  CAS  Google Scholar 

  12. Kurman RJ, Scully RE. Clear cell carcinoma of the endometrium. An analysis of 21 cases. Cancer 1976; 37:872–882.

    PubMed  CAS  Google Scholar 

  13. Melhem MF, Tobon H. Mucinous adenocarcinoma of the endometrium: A clinico-pathological review of 18 cases. Int J Gynecol Pathol 1987; 6:347–355.

    PubMed  CAS  Google Scholar 

  14. Ross JC, Eifel PJ, Cox RS, Kempson RL, Hendrickson MR. Primary mucinous adenocarcinoma of the endometrium. A clinicopathologic and histochemical study. Am J Surg Pathol 1983; 7:715–729.

    PubMed  CAS  Google Scholar 

  15. Chen JL, Trost DC, Wilkinson EJ. Endometrial papillary adenocarcinomas: Two clinicopathological types. Int J Gynecol Pathol 1985; 4:279–288.

    PubMed  CAS  Google Scholar 

  16. Mittal KR, Schwartz PE, Barwick KW. Architectural (FIGO) grading, nuclear grading, and other prognostic indicators in stage I endometrial adenocarcinoma with identification of high-risk and low-risk groups. Cancer 1988; 61:538–545.

    PubMed  CAS  Google Scholar 

  17. Wilson TO, Podratz KC, Gaffey TA, Malkasian GD, O’Brien PC, Naessens JM. Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. Am J Obstet Gynecol 1990; 162:418–426.

    PubMed  CAS  Google Scholar 

  18. Zaino RJ, Kurman R, Herbold D, Gliedman J, Bundy BN, Voet R, et al. The significance of squamous differentiation in endometrial carcinoma—Data from a Gynecologic Oncology Group study. Cancer 1991; 68:2293–2302.

    PubMed  CAS  Google Scholar 

  19. Abeler VM, Kjorstad KE. Endometrial adenocarcinoma with squamous cell differentiation. Cancer 1992; 69:488–495.

    PubMed  CAS  Google Scholar 

  20. Abeler VM, Kjorstad KE. Serous papillary carcinoma of the endometrium: A histopathological study of 22 cases. Gynecol Oncol 1990; 39:266–271.

    PubMed  CAS  Google Scholar 

  21. Abeler VM, Kjorstad KE. Clear cell carcinoma of the endometrium: A histopathological and clinical study of 97 cases. Gynecol Oncol 1991; 40:207–217.

    PubMed  CAS  Google Scholar 

  22. Webb GA, Lagios MD. Clear cell carcinoma of the endometrium. Am J Obstet Gynecol 1987; 156:1486–1491.

    PubMed  CAS  Google Scholar 

  23. Dunton CJ, Balsara G, McFarland M, Hernandez E. Uterine papillary serous carcinoma. A review. Obstet Gynecol Survey 1991; 46:97–102.

    CAS  Google Scholar 

  24. Fanning J, Evans MC, Peters AJ, Samuel M, Harmon ER, Bates JS. Endometrial adenocarcinoma histologic subtypes: Clinical and pathologic profile. Gynecol Oncol 1989; 32:288–291.

    PubMed  CAS  Google Scholar 

  25. Kanbour-Shakir A, Tobon H. Primary clear cell carcinoma of the endometrium. A clinicopathologic study of 20 cases. Int J Gynecol Pathol 1991; 10:67–78.

    PubMed  CAS  Google Scholar 

  26. Kadar N, Malfetano JH, Homesley HD. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: Implications for therapy. Obstet Gynecol 1992; 80:655–659.

    PubMed  CAS  Google Scholar 

  27. DiSaia PJ, Creasman WT. Clinical gynecologic oncology, 6th ed. St. Louis: Mosby-Year Book, 2002.

    Google Scholar 

  28. Scully RE, Bonfiglio TA, Kurman RE, Silverberg SG, Wilkinson EJ. Histological typing of female genital tract tumours. New York: Springer-Verlag; 1994.

    Google Scholar 

  29. Silverberg SG, Kurman RJ, Nogales F, Mutter GL, Kubik-Nuch RA, Tavassoli FA. Tumours of the uterine corpus. Epithelial tumours and related lesions. In: World Health Organization Classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Tavassoli FA, Devilee P, eds. Lyon: IARC Press; 2003: 221–232.

    Google Scholar 

  30. Benedet JL, Bender H, Jones H, III, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000; 70:209–262.

    PubMed  CAS  Google Scholar 

  31. Hendrickson MR, Ross JC, Kempson RL. Toward the development of morphologic criteria for well-differentiated adenocarcinoma of the endometrium. Am J Surg Pathol 1983; 7:819–838.

    PubMed  CAS  Google Scholar 

  32. Kurman RJ, Norris HJ. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 1982; 49:2547–2557.

    PubMed  CAS  Google Scholar 

  33. Norris HJ, Tavassoli FA, Kurman RJ. Endometrial hyperplasia and carcinoma. Diagnostic considerations. Am J Surg Pathol 1983; 7:839–847.

    PubMed  CAS  Google Scholar 

  34. Kraus FT. High-risk and premalignant lesions of the endometrium. Am J Surg Pathol 1985; 9(Suppl):31–40.

    Google Scholar 

  35. Ronnett BM, Kurman RJ. Precursor lesions of endometrial carcinoma. In: Kurman R, ed. Blaustein’s pathology of the female genital tract. 5th ed. New York: Springer-Verlag, 2002: 467–500.

    Google Scholar 

  36. Lehman MB, Hart WR. Simple and complex hyperplastic papillary proliferations of the endometrium: A clinicopathologic study of nine cases of apparently localized papillary lesions with fibrovascular stromal cores and 242 10. Endometrial Carcinoma epithelial metaplasia. Am J Surg Pathol 2001; 25:1347–1354.

    PubMed  CAS  Google Scholar 

  37. King A, Seraj IM, Wagner RJ. Stromal invasion in endometrial carcinoma. Am J Obstet Gynecol 1984; 149:10–14.

    PubMed  CAS  Google Scholar 

  38. Silverberg SG, Kurman RJ. Tumors of the uterine corpus and gestational trophoblastic disease. Atlas of tumor pathology, 3rd series, Fascicle 3. Washington, DC: Armed Forces Institute of Pathology, 1992.

    Google Scholar 

  39. Winkler B, Alvarez S, Richart RM, Crum CP. Pitfalls in the diagnosis of endometrial neoplasia. Obstet Gynecol 1984; 64:185–194.

    PubMed  CAS  Google Scholar 

  40. Crum CP, Richart RM, Fenoglio CM. Adenoacanthosis of the endometrium. A clinicopathologic study in premenopausal women. Am J Surg Pathol 1981; 5:15.

    PubMed  CAS  Google Scholar 

  41. Hendrickson MR, Kempson RL. Endometrial epithelial metaplasias: Proliferations frequently misdiagnosed as adenocarcinoma. Report of 89 cases and proposed classification. Am J Surg Pathol 1980; 4:525–542.

    PubMed  CAS  Google Scholar 

  42. Blaustein A. Morular metaplasia misdiagnosed as adenoacanthoma in young women with polycystic ovarian disease. Am J Surg Pathol 1982; 6:223.

    PubMed  CAS  Google Scholar 

  43. Clement PB, Young RH. Endometrioid carcinoma of the uterine corpus: A review of its pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 2002; 9:145–184.

    PubMed  Google Scholar 

  44. Andersen WA, Taylor PT, Fechner RE, Pinkerton JAV. Endometrial metaplasia associated with endometrial carcinoma. Am J Obstet Gynecol 1987; 157:597–604.

    PubMed  CAS  Google Scholar 

  45. Clement PB. Pathology of the uterine corpus. Hum Pathol 1991; 22:776–791.

    PubMed  CAS  Google Scholar 

  46. Zaman SS, Mazur MT. Endometrial papillary syncytial change. A nonspecific alteration associated with active breakdown. Am J Clin Pathol 1993; 99:741–745.

    PubMed  CAS  Google Scholar 

  47. Kaku T, Tsukamoto N, Tsuruchi N, Sugihara K, Kamura T, Nakano H. Endometrial metaplasia associated with endometrial carcinoma. Obstet Gynecol 1992; 80:812–816.

    PubMed  CAS  Google Scholar 

  48. Rorat E, Wallach RC. Papillary metaplasia of the endometrium: Clinical and histopathologic considerations. Obstet Gynecol 1984; 64:90S–92S.

    PubMed  CAS  Google Scholar 

  49. Sherman ME, Mazur MT, Kurman RJ. Benign diseases of the endometrium. In: Kurman RJ, ed. Blaustein’s pathology of the female genital tract. 5th ed. New York: Springer-Verlag; 2002: 421–466.

    Google Scholar 

  50. Mazur MT. Atypical polypoid adenomyomas of the endometrium. Am J Surg Pathol 1981; 5:473–482.

    PubMed  CAS  Google Scholar 

  51. Young RH, Treger T, Scully RE. Atypical polypoid adenomyoma of the uterus. A report of 27 cases. Am J Clin Pathol 1986; 86:139–145.

    PubMed  CAS  Google Scholar 

  52. Iezzoni JC, Mills SE. Nonneoplastic endometrial signet-ring cells. Vacuolated decidual cells and stromal histiocytes mimicking adenocarcinoma. Am J Clin Pathol 2001; 115:249–255.

    PubMed  CAS  Google Scholar 

  53. Scully RE, Poulson H, Sobin LH. International Histological Classification and Typing of Female Genital Tract Tumours. Berlin: Springer-Verlag; 1994.

    Google Scholar 

  54. Demopoulos RI, Dubin N, Noumoff J, et al. Prognostic significance of squamous differentiation in stage I endometrial adenocarcinoma. Obstet Gynecol 1986; 68:245–250.

    PubMed  CAS  Google Scholar 

  55. Zaino RJ, Kurman RJ, Diana KL, Morrow CP. The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A Gynecologic Oncology Group study. Cancer 1995; 75:81–86.

    PubMed  CAS  Google Scholar 

  56. Nordstrom B, Strang P, Lindgren A, Bergstrom R, Tribukait B. Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expression. Anticancer Res 1996; 16:899–904.

    PubMed  CAS  Google Scholar 

  57. Ayhan A, Taskiran C, Yuce K, Kucukali T. The prognostic value of nuclear grading and the revised FIGO grading of endometrial adenocarcinoma. Int J Gynecol Pathol 2003; 22:71–74.

    PubMed  CAS  Google Scholar 

  58. Alkushi A, Lim P, Coldman A, Huntsman D, Miller D, Gilks B. Assessment of a novel grading system for endometrial carcinoma. Mod Pathol 2003; 16:180A.

    Google Scholar 

  59. Christopherson WM, Alberhasky RC, Connelly PJ. Carcinoma of the endometrium: II. Papillary adenocarcinoma: A clinical pathologic study of 46 cases. Am J Clin Pathol 1982; 77:534–540.

    PubMed  CAS  Google Scholar 

  60. Daniel AG, Peters WA, III. Accuracy of office and operating room curettage in the grading of endometrial carcinoma. Obstet Gynecol 1988; 71:612–614.

    PubMed  CAS  Google Scholar 

  61. Cowles TA, Magrina JF, Masterson BJ, Capen CV. Comparison of clinical and surgical staging in patients with endometrial carcinoma. Obstet Gynecol 1985; 66:413–416.

    PubMed  CAS  Google Scholar 

  62. Piver MS, Lele SB, Barlow JJ, Blumenson L. Paraaortic lymph node evaluation in stage I endometrial cancer. Obstet Gynecol 1982; 59:97–100.

    PubMed  CAS  Google Scholar 

  63. Larson DM, Johnson KK, Broste SK, Krawisz BR, Kresl JJ. Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol 1995; 86:38–42.

    PubMed  CAS  Google Scholar 

  64. Obermair A, Geramou M, Gucer F, Denison U, Graf AH, Kapshammer E, et al. Endometrial cancer: Accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy. Int J Gynecol Cancer 1999; 9:383–386.

    PubMed  Google Scholar 

  65. Nielsen AL, Thomsen HK, Nyholm HCJ. Evaluation of the reproducibility of the revised 1988 International Federation of Gynecology and Obstetrics grading system of endometrial cancers with special emphasis on nuclear grading. Cancer 1991; 68:2303–2309.

    PubMed  CAS  Google Scholar 

  66. Zaino RJ, Silverberg SG, Norris HJ, Bundy BN, Morrow CP, Okagaki T. The prognostic value of nuclear versus architectural grading in endometrial adenocarcinoma. A Gynecologic Oncology Group study. Int J Gynecol Pathol 1994; 13:29–36.

    PubMed  CAS  Google Scholar 

  67. Lax SF, Kurman RJ, Pizer ES, Wu L, Ronnett BM. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. Am J Surg Pathol 2000; 24:1201–1208.

    PubMed  CAS  Google Scholar 

  68. Taylor RR, Zeller J, Lieberman RW, O’Connor DM. An analysis of two versus three grades for endometrial carcinoma. Gynecol Oncol 1999; 74:3–6.

    PubMed  CAS  Google Scholar 

  69. Scholten AN, Smit VTHBM, Beerman H, van Putten WLJ, Creutzberg CL. Prognostic significance and interobserver variablility of histologic grading systems form endometrial carcinoma. Cancer 2004; 100:764–772.

    PubMed  Google Scholar 

  70. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma. A highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 1982; 6:93–108.

    PubMed  CAS  Google Scholar 

  71. Clement PB, Scully RE. Endometrial hyperplasia and carcinoma. In: Clement PB, Young RH, ed. Tumors and tumorlike lesions of the uterine corpus and cervix. New York: Churchill Livingstone; 1993: 181–264.

    Google Scholar 

  72. Hendrickson MR, Kempson RL. Ciliated carcinoma-a variant of endometrial adenocarcinoma. A report of 10 cases. Int J Gynecol Pathol 1983; 2:1–12.

    PubMed  CAS  Google Scholar 

  73. Gould PR, Li L, Henderson DW, Barter RA, Papadimitriou JM. Cilia and ciliogenesis in endometrial adenocarcinomas. Arch Pathol Lab Med 1986; 110:326–330.

    PubMed  CAS  Google Scholar 

  74. Tobon H, Watkins GJ. Secretory adenocarcinoma of the endometrium. Int J Gynecol Pathol 1985; 4:328–335.

    PubMed  CAS  Google Scholar 

  75. Dawagne MP, Silverberg SG. Foam cells in endometrial carcinoma. Gynecol Oncol 1982; 13:67–75.

    PubMed  CAS  Google Scholar 

  76. Silver SA, Sherman ME. Morphologic and immunophenotypic characterization of foam cells in endometrial lesions. Int J Gynecol Pathol 1998; 17:140–145.

    PubMed  CAS  Google Scholar 

  77. Tiltman AJ. Mucinous carcinoma of the endometrium. Obstet Gynecol 1980; 55:244–247.

    PubMed  CAS  Google Scholar 

  78. Czernobilsky B, Katz Z, Lancet M, Gaton E. Endocervical type epithelium in endometrial carcinoma: A report of 10 cases with emphasis on histochemical methods for differential diagnosis. Am J Surg Pathol 1980; 4:481–489.

    PubMed  CAS  Google Scholar 

  79. Young RH, Scully RE. Uterine carcinomas simulating microglandular hyperplasia. A report of six cases. Am J Surg Pathol 1992; 16:1092–1097.

    PubMed  CAS  Google Scholar 

  80. Zaloudek C, Hayashi GM, Ryan IP, Powell CB, Miller TR. Microglandular adenocarcinoma of the endometrium: A form of mucinous adenocarcinoma that may be confused with microglandular hyperplasia of the cervix. Int J Gynecol Pathol 1997; 16:52–59.

    PubMed  CAS  Google Scholar 

  81. Lee KR, Belinson JL. Recurrence in noninvasive endometrial carcinoma. Relationship to uterine papillary serous carcinoma. Am J Surg Pathol 1991; 15:965–973.

    PubMed  CAS  Google Scholar 

  82. Sherman ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ. Uterine serous carcinoma—a morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 1992; 16:600–610.

    PubMed  CAS  Google Scholar 

  83. Lee KR, Belinson JL. Papillary serous adenocarcinoma of the endometrium: A clinicopathologic study of 19 cases. Gynecol Oncol 1992; 46:51–54.

    PubMed  CAS  Google Scholar 

  84. Carcangiu ML, Chambers JT. Uterine papillary serous carcinoma—A study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol 1992; 47:298–305.

    PubMed  CAS  Google Scholar 

  85. Demopoulos RI, Genega E, Vamvakas E, Carlson E, Mittal K. Papillary carcinoma of the endometrium: Morphometric predictors of survival. Int J Gynecol Pathol 1996; 15:110–118.

    PubMed  CAS  Google Scholar 

  86. Sutton GP, Brill L, Michael H, et al. Malignant papillary lesions of the endometrium. Gynecol Oncol 1987; 27:294–304.

    PubMed  CAS  Google Scholar 

  87. Lax SF, Kendall B, Tashiro H, Slebos RJ, Hedrick L. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways. Cancer 2000; 88:814–824.

    PubMed  CAS  Google Scholar 

  88. Sherman ME, Bur ME, Kurman RJ. p53 in endometrial cancer and its putative precursors: Evidence for diverse pathways of tumorigenesis. Hum Pathol 1995; 26:1268–1274.

    PubMed  CAS  Google Scholar 

  89. Tashiro H, Isacson C, Levine R, Kurman RJ, Cho KR, Hedrick L. p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol 1997; 150:177–185.

    PubMed  CAS  Google Scholar 

  90. Kovalev S, Marchenko ND, Gugliotta BG, Chalas E, Chumas J, Moll UM. Loss of p53 function in uterine papillary serous carcinoma. Hum Pathol 1998; 29(6):613–619.

    PubMed  CAS  Google Scholar 

  91. Lax SF, Pizer ES, Ronnett BM, Kurman RJ. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Hum Pathol 1998; 29:551–558.

    PubMed  CAS  Google Scholar 

  92. Carcangiu ML, Chambers JT, Voynick IM, Pirro M, Schwartz PE. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: Clinical and histologic correlations. Am J Clin Pathol 1990; 94(3):247–254.

    PubMed  CAS  Google Scholar 

  93. Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H, Jones MW. Immunohistochemical profile of endometrial adenocarcinoma: A study of 61 cases and review of the literature. Mod Pathol 2000; 13:379–388.

    PubMed  CAS  Google Scholar 

  94. Lax SF, Pizer ES, Ronnett BM, Kurman RJ. Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation. Hum Pathol 1998; 29:924–931.

    PubMed  CAS  Google Scholar 

  95. Chambers JT, Merino M, Kohorn EI, et al. Uterine papillary serous carcinoma. Obstet Gynecol 1987; 69:109.

    PubMed  CAS  Google Scholar 

  96. Jeffrey JF, Krepart GV, Lotocki RJ. Papillary serous adenocarcinoma of the endometrium. Obstet Gynecol 1986; 67:670.

    PubMed  CAS  Google Scholar 

  97. Woolas RP, Williams K, McCartney AJ. Uterine papillary serous carcinoma in a 32-year-old with Turner’s syndrome. Gynecol Oncol 1994; 52:395–401.

    PubMed  CAS  Google Scholar 

  98. Cirisano FD, Jr, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, et al. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma. Gynecol Oncol 1999; 74:385–394.

    PubMed  Google Scholar 

  99. Evans-Metcalf ER, Brooks SE, Reale FR, Baker SP. Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 1998; 91:349–354.

    PubMed  CAS  Google Scholar 

  100. Silva EG, Jenkins R. Serous carcinoma in endometrial polyps. Mod Pathol 1990; 3:120–128.

    PubMed  CAS  Google Scholar 

  101. McCluggage WG, Sumathi VP, McManus DT. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: Report of 5 cases, including 2 associated with tamoxifen therapy. Hum Pathol 2003; 34:939–943.

    PubMed  CAS  Google Scholar 

  102. Aquino-Parsons C, Lim P, Wong F, Mildenberger M. Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage 1a and 1b endometrial adenocarcinoma: treatment implications. Gynecol Oncol 1998; 71:83–86.

    PubMed  CAS  Google Scholar 

  103. Wheeler DT, Bell KA, Kurman RJ, Sherman ME. Minimal uterine serous carcinoma: Diagnosis and clinicopathologic correlation. Am J Surg Pathol 2000; 24:797–806.

    PubMed  CAS  Google Scholar 

  104. Carcangiu ML, Tan LK, Chambers JT. Stage IA uterine serous carcinoma: A study of 13 cases. Am J Surg Pathol 1997; 21:1507–1514.

    PubMed  CAS  Google Scholar 

  105. Baergen RN, Warren CD, Isacson C, Ellenson LH. Early uterine serous carcinoma: Clonal origin of extrauterine disease. Int J Gynecol Pathol 2001; 20(3):214–219.

    PubMed  CAS  Google Scholar 

  106. Gehrig PA, Groben PA, Fowler WC, Jr, Walton LA, Van Le L. Noninvasive papillary serous carcinoma of the endometrium. Obstet Gynecol 2001; 97:153–157.

    PubMed  CAS  Google Scholar 

  107. Soslow RA, Pirog E, Isacson C. Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis. Am J Surg Pathol 2000; 24:726–732.

    PubMed  CAS  Google Scholar 

  108. Chan JK, Loizzi V, Youssef M, Osann K, Rutgers J, Vasilev SA, et al. Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gynecol Oncol 2003; 90:181–185.

    PubMed  Google Scholar 

  109. Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, et al. Uterine papillary serous carcinoma (UPSC): A single institution review of 129 cases. Gynecol Oncol 2003; 91:463–469.

    PubMed  Google Scholar 

  110. Sakuragi N, Hareyama H, Todo Y, Yamada H, Yamamoto R, Fujino T, et al. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma. Acta Obstet Gynecol Scand 2000; 79:311–316.

    PubMed  CAS  Google Scholar 

  111. Abeler VM, Vergote IB, Kjorstad KE, Trope CG. Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern. Cancer 1996; 78:1740–1747.

    PubMed  CAS  Google Scholar 

  112. Simon A, Kopolovic J, Beyth Y. Primary squamous cell carcinoma of the endometrium. Gynecol Oncol 1988; 31:454–461.

    PubMed  CAS  Google Scholar 

  113. Melin JR, Wanner L, Schulz DM, Cassell EE. Primary squamous cell carcinoma of the endometrium. Obstet Gynecol 1979; 53:115–119.

    PubMed  CAS  Google Scholar 

  114. Goodman A, Zukerberg LR, Rice LW, Fuller AF, Young RH, Scully RE. Squamous cell carcinoma of the endometrium: A report of eight cases and a review of the literature. Gynecol Oncol 1996; 61:54–60.

    PubMed  CAS  Google Scholar 

  115. Houissa-Vuong S, Catanzano-Laroudie M, Baviera E, Balaton A, Galet B, Gedeon I, et al. Primary squamous cell carcinoma of the endometrium: Case history, pathologic findings, and discussion. Diagn Cytopathol 2002; 27:291–293.

    PubMed  CAS  Google Scholar 

  116. Ryder DE. Verrucous carcinoma of the endometrium—a unique neoplasm with long survival. Obstet Gynecol 1982; 59:78S–80S.

    PubMed  CAS  Google Scholar 

  117. Spiegel GW, Austin RM, Gelven PL. Transitional cell carcinoma of the endometrium. Gynecol Oncol 1996; 60:325–330.

    PubMed  CAS  Google Scholar 

  118. Lininger RA, Ashfaq R, Albores-Saavedra J, Tavassoli FA. Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation. Cancer 1997; 79:1933–1943.

    PubMed  CAS  Google Scholar 

  119. Abeler VM, Kjorstad KE, Nesland JM. Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases. Cancer 1991; 68:98–105.

    PubMed  CAS  Google Scholar 

  120. Huntsman DG, Clement PB, Gilks CB, Scully RE. Small-cell carcinoma of the endometrium. A clinicopathological study of sixteen cases. Am J Surg Pathol 1994; 18:364–375.

    PubMed  CAS  Google Scholar 

  121. Olson N, Twiggs L, Sibley R. Small-cell carcinoma of the endometrium: Light microscopic and ultrastructural study of a case. Cancer 1982; 50:760–765.

    PubMed  CAS  Google Scholar 

  122. Paz RA, Frigerio B, Sundblad AS, Eusebi V. Small-cell (oat cell) carcinoma of the endometrium. Arch Pathol Lab Med 1985; 109:270–272.

    PubMed  CAS  Google Scholar 

  123. Manivel C, Wick MR, Sibley TK. Neuroendocrine differentiation in mullerian neoplasms. An immunohistochemical study of a “pure” endometrial small-cell carcinoma and a mixed mullerian tumor containing small-cell carcinoma. Am J Clin Pathol 1986; 86:438–443.

    PubMed  CAS  Google Scholar 

  124. Meydanli MM, Erguvan R, Altinok MT, Ataoglu O, Kafkasli A. Rare case of neuroendocrine small cell carcinoma of the endometrium with paraneoplastic membranous glomerulonephritis. Tumori 2003; 89:213–217.

    PubMed  Google Scholar 

  125. Pesce C, Merino MJ, Chambers JT, Nogales F. Endometrial carcinoma with trophoblastic differentiation. An aggressive form of uterine cancer. Cancer 1991; 68:1799–1802.

    PubMed  CAS  Google Scholar 

  126. Deligdisch L, Kase NG, Bleiweiss IJ. Endometrial cancer in elderly women: A histologic and steroid receptor study. Gerontology 2000; 46:17–21.

    PubMed  CAS  Google Scholar 

  127. Kalir T, Seijo L, Deligdisch L, Cohen C. Endometrial adenocarcinoma with choriocarcinomatous differentiation in an elderly virginal woman. Int J Gynecol Pathol 1995; 14:266–269.

    PubMed  CAS  Google Scholar 

  128. Savage J, Subby W, Okagaki T. Adenocarcinoma of the endometrium with trophoblastic differentiation and metastases as choriocarcinoma: A case report. Gynecol Oncol 1987; 26:257–262.

    PubMed  CAS  Google Scholar 

  129. Tunc M, Simsek T, Trak B, Uner M. Endometrium adenocarcinoma with choriocarcinomatous differentiation: A case report. Eur J Gynaecol Oncol 1998; 19:489–491.

    PubMed  CAS  Google Scholar 

  130. Black K, Sykes P, Ostor AG. Trophoblastic differentiation in an endometrial carcinoma. Aust N Z J Obstet Gynaecol 1998; 38:472–473.

    PubMed  CAS  Google Scholar 

  131. Arends J, Willebrand D, Gans HJD, Swaen GJV, Bosman FT. Adenocarcinoma of the endometrium with glassy cell features—Immunohistochemical observations. Histopathology 1984; 8:873–879.

    PubMed  CAS  Google Scholar 

  132. Christopherson WM, Alberhasky RC, Connelly PJ. Glassy cell carcinoma of the endometrium. Hum Pathol 1982; 13:418–421.

    PubMed  CAS  Google Scholar 

  133. Pitman MB, Young RH, Clement PB, Dickersin GR, Scully RE. Endometrioid carcinoma of the ovary and endometrium, oxyphilic cell type: A report of nine cases. Int J Gynecol Pathol 1994; 13:290–301.

    PubMed  CAS  Google Scholar 

  134. Mooney EE, Robboy SJ, Hammond CB, Berchuck A, Bentley RC. Signet-ring cell carcinoma of the endometrium: A primary tumor masquerading as a metastasis. Int J Gynecol Pathol 1997; 16:169–172.

    PubMed  CAS  Google Scholar 

  135. Vargas MP, Merino MJ. Lymphoepitheliomalike carcinoma: An unusual variant of endometrial cancer. A report of two cases. Int J Gynecol Pathol 1998; 17:272–276.

    PubMed  CAS  Google Scholar 

  136. Jones MA, Young RH, Scully RE. Endometrial adenocarcinoma with a component of giant cell carcinoma. Int J Gynecol Pathol 1991; 10:260–270.

    PubMed  CAS  Google Scholar 

  137. Joseph MG, Fellows FG, Hearn SA. Primary endodermal sinus tumor of the endometrium. A clinicopathologic, immunocytochemical, and ultrastructural study. Cancer 1990; 63:297–302.

    Google Scholar 

  138. Ohta M, Sakakibara K, Mizuno K, Kano T, Matsuzawa K, Tomoda Y, et al. Successful treatment of primary endodermal sinus tumor of the endometrium. Gynecol Oncol 1988; 31:357–364.

    PubMed  CAS  Google Scholar 

  139. Hoshida Y, Nagakawa T, Mano S, Taguchi K, Aozasa K. Hepatoid adenocarcinoma of the endometrium associated with alpha-fetoprotein production. Int J Gynecol Pathol 1996; 15:266–269.

    PubMed  CAS  Google Scholar 

  140. Daya D, Lukka H, Clement PB. Primitive neuroectodermal tumors of the uterus—A report of four cases. Hum Pathol 1992; 23:1120–1129.

    PubMed  CAS  Google Scholar 

  141. Hendrickson MR, Scheithauer BW. Primitive neuroectodermal tumor of the endometrium: Report of two cases, one with electron microscopic observations. Int J Gynecol Pathol 1986; 5:249–259.

    PubMed  CAS  Google Scholar 

  142. Sinkre P, Albores-Saavedra J, Miller DS, Copeland LJ, Hameed A. Endometrial endometrioid carcinomas associated with Ewing sarcoma/peripheral primitive neuroectodermal tumor. Int J Gynecol Pathol 2000; 19:127–132.

    PubMed  CAS  Google Scholar 

  143. Sorensen JB, Schultze HR, Madsen EL, Holund B. Primitive neuroectodermal tumor (PNET) of the uterine cavity. Eur J Obstet Gynecol Reprod Biol 1998; 76:181–184.

    PubMed  CAS  Google Scholar 

  144. Fraggetta F, Magro G, Vasquez E. Primitive neuroectodermal tumour of the uterus with focal cartilaginous differentiation. Histopathology 1997; 30:483–485.

    PubMed  CAS  Google Scholar 

  145. Bittencourt AL, Britto JF, Fonseca LEJ. Wilms’ tumor of the uterus: The first report of the literature. Cancer 1981; 47:2496–2499.

    PubMed  CAS  Google Scholar 

  146. Muc RS, Grayson W, Grobbelaar JJ. Adult extrarenal Wilms tumor occurring in the uterus. Arch Pathol Lab Med 2001; 125:1081–1083.

    PubMed  CAS  Google Scholar 

  147. Staebler A, Sherman ME, Zaino RJ, Ronnett BM. Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas. Am J Surg Pathol 2002; 26(8):998–1006.

    PubMed  Google Scholar 

  148. Kamoi S, AlJuboury MI, Akin MR, Silverberg SG. Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: Another viewpoint. Int J Gynecol Pathol 2002; 21:217–223.

    PubMed  Google Scholar 

  149. McCluggage WG, Sumathi VP, McBride HA, Patterson A. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol 2002; 21:11–15.

    PubMed  Google Scholar 

  150. Zhang X, Lin Z, Lee ES, Kim I. Immunohistochemical profiles of endometrial and endocervical adenocarcinomas. Mod Pathol 16 [217A]. 2003.

    Google Scholar 

  151. Ansari-Lari MA, Staebler A, Ronnett BM. Distinction of endocervical and endometrial adenocarcinomas: p16 expression correlated with human papillomavirus (HPV) DNA detection by in situ hybridization (ISH). Mod Pathol 2003; 16:180A.

    Google Scholar 

  152. McCluggage WG, Jenkins D. p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma. Int J Gynecol Pathol 2003; 22:231–235.

    PubMed  CAS  Google Scholar 

  153. Dabbs DJ, Geisinger KR, Norris HT. Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns. Am J Surg Pathol 1986; 10:568–576.

    PubMed  CAS  Google Scholar 

  154. Castrillon DH, Lee KR, Nucci MR. Distinction between endometrial and endocervical adenocarcinoma: An immunohistochemical study. Int J Gynecol Pathol 2002; 21:4–10.

    PubMed  Google Scholar 

  155. Cohen C, Shulman G, Budgeon LR. Endocervical and endometrial adenocarcinoma: An immunoperoxidase and histochemical study. Am J Surg Pathol 1982; 6:151–157.

    PubMed  CAS  Google Scholar 

  156. Tamimi HK, Gown AM, Kimdeobald J, Figge DC, Greer BE, Cain JM. The utility of immunocytochemistry in invasive adenocarcinoma of the cervix. Am J Obstet Gynecol 1992; 166:1655–1662.

    PubMed  CAS  Google Scholar 

  157. Maes G, Fleuren GJ, Bara J, Nap M. The distribution of mucins, carcinoembryonic antigen, and mucus-associated antigens in endocervical and endometrial adenocarcinomas. Int J Gynecol Pathol 1988; 7:112–122.

    PubMed  CAS  Google Scholar 

  158. Kumar A, Schneider V. Metastases to the uterus from extrapelvic primary tumors. Int J Gynecol Pathol 1983; 2:134–140.

    PubMed  CAS  Google Scholar 

  159. Kumar NB, Hart WR. Metastases to the uterine corpus from extagenital cances. A clinicopathologic study of 63 cases. Cancer 1982; 50:2163–2169.

    PubMed  CAS  Google Scholar 

  160. Mazur MT, Hsueh S, Gersell DJ. Metastases to the female genital tract. Analysis of 325 cases. Cancer 1984; 53:1978–1984.

    PubMed  CAS  Google Scholar 

  161. Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary: A clinicopathologic study of 34 cases. Hum Pathol 1985; 16:28–34.

    PubMed  CAS  Google Scholar 

  162. Eifel P, Hendrickson M, Ross J, Ballon S, Martinez A, Kempson RL. Simultaneous presentation of carcinoma involving the ovary and uterine corpus. Cancer 1982; 50:163–170.

    PubMed  CAS  Google Scholar 

  163. Gown AM. Immunohistochemical determination of primary sites of carcinomas. J Histotechnol 1999; 22:209–215.

    Google Scholar 

  164. Agoff SN, Grieco VS, Garcia R, Gown AM. Immunohistochemical distinction of endometrial stromal sarcoma and cellular leiomyoma. Appl Immunohistochem Mol Morphol 2001; 9:164–169.

    PubMed  CAS  Google Scholar 

  165. Randall TC, Kurman RJ. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 1997; 90:434–440.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Upstate Medical University, State University of New York, Syracuse, NY 13210

    Michael T. Mazur MD (Clinical Professor of Pathology)

  2. ClearPath Diagnostics, Syracuse, NY 13202, USA

    Michael T. Mazur MD (Clinical Professor of Pathology)

  3. Departments of Gynecology, Obstetrics and Pathology, The Johns Hopkins Hospital, Baltimore, MD 21231, USA

    Robert J. Kurman MD (Richard W. TeLinde, Distinguished Professor)

  4. The Johns Hopkins University, School of Medicine, Baltimore, MD 21231, USA

    Robert J. Kurman MD (Richard W. TeLinde, Distinguished Professor)

Authors
  1. Michael T. Mazur MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert J. Kurman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Mazur, M.T., Kurman, R.J. (2005). Endometrial Carcinoma. In: Diagnosis of Endometrial Biopsies and Curettings. Springer, New York, NY. https://doi.org/10.1007/978-0-387-26321-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-26321-2_10

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-98615-9

  • Online ISBN: 978-0-387-26321-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation